Healthcare -
Biotechnology - NASDAQ - NL
$ 18.36
5.21 %
$ 992 M
Market Cap
-6.85
P/E
Price Target
Average
99.19%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
51.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pharvaris N.V.
Wall Street analysts predict an average 1-year price target for PHVS of $36.6 , with forecasts ranging from
a
low of
$22 to a high of $50 .
PHVS Lowest Price Target
Wall Street Target
22 USD
19.83%
PHVS Average Price Target
Wall Street Target
36.6 USD
99.19%
PHVS Highest Price Target
Wall Street Target
50 USD
172.33%
REVENUE FORECAST
Revenue Forecast Chart PHVS
EBIT FORECAST
EBIT Forecast Chart PHVS
NET INCOME FORECAST
Net Income Chart PHVS